|
Volumn 5, Issue 9, 2004, Pages 663-666
|
Treatment synergy of silicon carbide-coated stenting and abciximab for complex coronary artery lesions: clinical results of a single-center study.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
BIOMATERIAL;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
SILICONE DERIVATIVE;
ANGIOCARDIOGRAPHY;
ARTICLE;
CHEMISTRY;
COMPARATIVE STUDY;
CORONARY ARTERY OBSTRUCTION;
DOSE RESPONSE;
DRUG ADMINISTRATION;
ELECTIVE SURGERY;
FEMALE;
FOLLOW UP;
HOSPITALIZATION;
HUMAN;
INSTRUMENTATION;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NORWAY;
PROSPECTIVE STUDY;
RADIOGRAPHY;
RISK ASSESSMENT;
STENT;
SURVIVAL RATE;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
COATED MATERIALS, BIOCOMPATIBLE;
COMBINED MODALITY THERAPY;
CORONARY ANGIOGRAPHY;
CORONARY STENOSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MALE;
MIDDLE AGED;
NORWAY;
PROSPECTIVE STUDIES;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SILICONES;
STENTS;
SURGICAL PROCEDURES, ELECTIVE;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 16644382493
PISSN: 1129471X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|